DMSO in NSAID Manufacturing: Ketoprofen and Beyond

Request A Sample

Several high-volume NSAIDs rely on dimethyl sulfoxide at a decisive synthetic or purification step. The aryl propionic acids ketoprofen and flurbiprofen use it to build their side chains, where solvent choice strongly affects yield. The COX-2 inhibitor celecoxib uses DMSO recrystallization to fix its crystalline polymorph, and diclofenac and naproxen draw on DMSO in cyclization and purification. Because these products are produced at large scale, even modest solvent-driven yield improvements carry substantial economic weight.

Ketoprofen Side-Chain Construction

Ketoprofen is a benzophenone bearing an α-methylacetic acid side chain, built through Willgerodt–Kindler-type rearrangement of an aryl ketone before hydrolysis to the propionic acid. DMSO dissolves the aromatic substrate and the intermediate enolate while remaining stable under the basic, warmed conditions. It solvates the alkali-metal cation of the enolate strongly, leaving the carbanion reactive, and it does not decompose at process temperature as DMF does.

Table 1: Ketoprofen side-chain step — DMSO versus DMF (industry practice)

Under comparable conditions the ketoprofen side-chain step gives about 68% yield in DMSO versus roughly 23% in DMF. The difference comes down to DMSO’s higher polarity and better cation solvation, which activate the carbanion, plus its thermal and basic stability. Flurbiprofen, which shares the aryl propionic acid framework, benefits from the same solvent selection in analogous steps.

Celecoxib Polymorph Control and Other NSAIDs

Celecoxib, a diaryl pyrazole COX-2 inhibitor, uses DMSO not as a reaction solvent but as a crystallization medium. Recrystallization from DMSO or DMSO–water selectively crystallizes the target polymorph and rejects process impurities. DMSO is also used to prepare celecoxib co-crystals, dissolving both the API and co-former for controlled co-crystallization.

Beyond these, diclofenac uses DMSO in diphenylamine cyclization and naproxen in recrystallization to upgrade intermediate and final material. In each case the function is either reaction support or selective dissolution for purification.

Grade Selection and Residual Solvent

For stages feeding directly into the API, pharmaceutical-grade DMSO meeting USP and European Pharmacopoeia specifications is required. For early-intermediate steps followed by crystallization or distillation, industrial-grade DMSO may be acceptable on cost. Under ICH Q3C, DMSO is a Class 3 residual solvent with a 5000 ppm limit, met by standard drying and isolation. Because DMSO boils near 189 °C it is not removed by simple evaporation; on scale it is either distilled under reduced pressure or flushed out during aqueous crystallization.